ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0925

Macrophages Produce Bone Anabolic Factors in Settings of Inflammation-Induced Bone Formation

Jia (Sijia) Chen1, Megan Hanlon2, Catherine Manning3, Susan MacLauchlan1, Paul Hoover4, Christian Jacome-Galarza5 and Ellen Gravallese6, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women’s Hospital, Boston, MA, 3Brigham and Women's Hospital, Dedham, MA, 4Brigham and Women's Hospital, SWAMPSCOTT, MA, 5Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 6Brigham and Women's Hospital, Harvard Medical School, Chestnut Hill, MA

Meeting: ACR Convergence 2024

Keywords: Animal Model, Autoinflammatory diseases, bone biology, Monocytes/macrophages, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Innate Immunity Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Understanding the pathogenesis of inflammation-induced pathologic bone formation remains a significant challenge in spondyloarthritis patients. We thought to uncover the pivotal events driving the inflammation-induced pathologic bone formation process. We hypothesized that innate immune sensing pathways activate bone anabolic factors in macrophages. This hypothesis was guided by our previous work that linked the accumulation of DNA and the cGAS/STING DNA-sensing pathway to pathologic bone accrual (1). In addition, in a mouse model of inflammatory arthritis, we aimed to characterize macrophage subsets and identify the signals responsible for mediating pathologic bone formation.

Methods: In in vitro studies, we transfected macrophages with poly(dA:dT) to activate cytosolic DNA-sensing pathways and assessed the impact of cGAS or STING deficiency on the production of bone anabolic factors, including Bone Morphogenic Protein (BMP2). We used Flt3Cre;Rosa26LSL-YFP as a cell lineage tracing system in mice. This system allowed for the separate identification of synovial macrophages derived from hematopoietic stem cell progenitors (HSC, F4/80 positive, YFP positive) or erythromyeloid progenitors (EMP, F4/80 positive, YFP negative). These mice were induced with serum transfer arthritis (STA), a model in which entheseal bone formation occurs at tibial sites. We purified HSC and EMP-derived synovial macrophages by fluorescence-activated cell sorting (FACS) and performed single-cell sequencing to characterize these macrophages.

Results: In in vitro transfection experiments, we demonstrated that the cGAS-STING DNA-sensing pathway plays a role in regulating BMP2 expression in macrophages. BMP2 mRNA was upregulated in macrophages transfected with poly(dA:dT), but not in transfected macrophages in which either cGAS or STING was deleted. In STA, we identified EMP-derived macrophages within inflamed synovial tissues as key producers of BMP2 and other cartilage and bone-anabolic proteins. In addition, we identified a distinct subset of macrophages shared by both EMP and HSC lineages. This subset of macrophages is highly enriched in the production of interferon-stimulated genes (ISGs), suggesting their potential modulation by the cGAS-STING or other DNA-sensing pathways.

Conclusion: Our data indicate that synovial macrophages have the potential to produce bone anabolic factors such as BMP2. This process may be activated through innate mechanisms, including the DNA-sensing pathway cGAS/STING. Furthermore, the discovery of macrophages within inflamed synovial tissues that respond to Type I interferons may provide key insights into pathogenesis and help explain why patients with inflammatory arthritis respond to JAK inhibition.

References: 1) Baum et al. STING Contributes to Abnormal Bone Formation Induced by Deficiency of DNase II in Mice. Arthritis Rheumatol. 69, 460-471 (2017).


Disclosures: J. Chen: None; M. Hanlon: None; C. Manning: None; S. MacLauchlan: None; P. Hoover: None; C. Jacome-Galarza: None; E. Gravallese: Beam Therapeutics, 11, CRISPR Therapeutics, 11, Editas Medicine, 11, Intellia Therapeutics, 11, New England Journal of Medicine, 3, NIH, 5, Rheumatology Research Foundation, 5.

To cite this abstract in AMA style:

Chen J, Hanlon M, Manning C, MacLauchlan S, Hoover P, Jacome-Galarza C, Gravallese E. Macrophages Produce Bone Anabolic Factors in Settings of Inflammation-Induced Bone Formation [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/macrophages-produce-bone-anabolic-factors-in-settings-of-inflammation-induced-bone-formation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/macrophages-produce-bone-anabolic-factors-in-settings-of-inflammation-induced-bone-formation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology